logo

For the Inventor, By the Inventor

Wayne, PA, United States of America

Andrew Fensome

This inventor holds 56 USPTO granted patents and 5 published patent applications, primarily in Progesterone Receptor Modulators (CPC class A61K). Top assignees: Wyeth, Ligand Pharmaceuticals, Inc., Other. Active years: 2001-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Fensome. Retrieved from https://idiyas.com/inventor/andrew-fensome

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 56 

% Patents Active = 35.7

Average Co-Inventor Count = 6.8

ph-index = 24

Forward Citations = 1,078(Granted Patents)

Forward Citations (Not Self Cited) = 717(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Wayne, PA (US) (2001 - 2012)
  • Stow, MA (US) (2013 - 2014)

Company Filing History:

goldMedal30 out of 1,309 
 
Wyeth
 patents
silverMedal3 out of 139 
 
Ligand Pharmaceuticals, Inc.
 patents
bronzeMedal26 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2001-2014

Loading Chart...
Areas of Expertise:
Progesterone Receptor
Thio-Oxindole Derivatives
Indoline Derivatives
Cyclothiocarbamate
Aryl Sulfonamides
Cyanopyrrole
Oxazolidine
Benzothiadiazinedioxide
Sulfonylated Heterocycles
Tricyclic Oxazolidone
Cyclocarbamate
Combination Regimens
56 patents (USPTO):Explore Patents
1. 8796266 - Cyclothiocarbamate derivatives as progesterone receptor modulators (2014-08-05),
2. 8466146 - Cyclothiocarbamate derivatives as progesterone receptor modulators (2013-06-18),
3. 8329690 - Cyclothiocarbamate derivatives as progesterone receptor modulators (2012-12-11),
4. 8242098 - Methods of treating hormone-related conditions using thio-oxindole derivatives (2012-08-14),
5. 7750038 - Sulfonylated heterocycles useful for modulation of the progesterone receptor (2010-07-06),
6. 7723332 - Aryl sulfonamides useful for modulation of the progesterone receptor (2010-05-25),
7. 7718652 - Substituted benzothiadiazinedioxide derivatives and methods of their use (2010-05-18),
8. 7652062 - Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof (2010-01-26),
9. 7652018 - Imidazolidin-2-one derivatives useful as PR modulators (2010-01-26),
10. 7649007 - Oxazolidine derivatives as PR modulators (2010-01-19),
11. 7645761 - Indoline derivatives (2010-01-12),
12. 7618990 - Oxazolidone derivatives as PR modulators (2009-11-17),
13. 7618989 - Tricyclic oxazolidone derivatives useful as PR modulators (2009-11-17),
14. 7601722 - Aryl sulfamide derivatives and methods of their use (2009-10-13),
15. 7569564 - Cyclothiocarbamate derivatives as progesterone receptor modulators (2009-08-04),

Title: The Innovative Mind of Andrew Fensome: Pioneering Progress in Medicine

Introduction:

Andrew Fensome, a renowned inventor based in Wayne, PA, has left a significant mark on the field of medicine with his groundbreaking patents and inventive spirit. With a total of 56 patents to his name, Fensome's contributions have revolutionized the realm of progesterone receptor modulation.

Latest Patents:

Among his notable patents is the revolutionary "Cyclothiocarbamate derivatives as progesterone receptor modulators." These compounds serve as progesterone receptor agonists for contraception and the treatment of progesterone-related maladies. Fensome's innovative structures have paved the way for advancements in women's health and hormone-related therapies.

Career Highlights:

Throughout his illustrious career, Fensome has lent his expertise to esteemed companies such as Wyeth, where he spearheaded cutting-edge research and development initiatives. His relentless pursuit of innovation has led to the creation of transformative solutions that have improved countless lives.

Collaborations:

Fensome's collaborative efforts with esteemed colleagues like Jay Edward Wrobel and Puwen Zhang have further enriched his inventive journey. Together, they have worked tirelessly to push the boundaries of scientific discovery and bring novel concepts to fruition.

Conclusion:

In conclusion, Andrew Fensome stands as a beacon of innovation in the field of medicine, with his numerous patents and groundbreaking discoveries reshaping the landscape of progesterone receptor modulation. His dedication to advancing healthcare through ingenuity and perseverance cements his legacy as a true pioneer in the realm of medical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…